1. Home
  2. UBXG vs UNCY Comparison

UBXG vs UNCY Comparison

Compare UBXG & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBXG
  • UNCY
  • Stock Information
  • Founded
  • UBXG 2018
  • UNCY 2016
  • Country
  • UBXG China
  • UNCY United States
  • Employees
  • UBXG N/A
  • UNCY N/A
  • Industry
  • UBXG
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • UBXG
  • UNCY Health Care
  • Exchange
  • UBXG Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • UBXG 67.8M
  • UNCY 56.4M
  • IPO Year
  • UBXG 2024
  • UNCY 2021
  • Fundamental
  • Price
  • UBXG $2.94
  • UNCY $4.20
  • Analyst Decision
  • UBXG
  • UNCY Strong Buy
  • Analyst Count
  • UBXG 0
  • UNCY 4
  • Target Price
  • UBXG N/A
  • UNCY $63.75
  • AVG Volume (30 Days)
  • UBXG 18.5K
  • UNCY 537.6K
  • Earning Date
  • UBXG 01-01-0001
  • UNCY 08-13-2025
  • Dividend Yield
  • UBXG N/A
  • UNCY N/A
  • EPS Growth
  • UBXG N/A
  • UNCY N/A
  • EPS
  • UBXG N/A
  • UNCY N/A
  • Revenue
  • UBXG $39,603,353.00
  • UNCY N/A
  • Revenue This Year
  • UBXG N/A
  • UNCY N/A
  • Revenue Next Year
  • UBXG N/A
  • UNCY $1,178.98
  • P/E Ratio
  • UBXG N/A
  • UNCY N/A
  • Revenue Growth
  • UBXG N/A
  • UNCY N/A
  • 52 Week Low
  • UBXG $2.36
  • UNCY $2.02
  • 52 Week High
  • UBXG $567.04
  • UNCY $11.00
  • Technical
  • Relative Strength Index (RSI)
  • UBXG N/A
  • UNCY 37.63
  • Support Level
  • UBXG N/A
  • UNCY $4.38
  • Resistance Level
  • UBXG N/A
  • UNCY $4.94
  • Average True Range (ATR)
  • UBXG 0.00
  • UNCY 0.24
  • MACD
  • UBXG 0.00
  • UNCY 0.01
  • Stochastic Oscillator
  • UBXG 0.00
  • UNCY 11.63

About UBXG U-BX Technology Ltd. Ordinary Shares

U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: